Copyright © SKINLABMEDISPA

What is M22?

M22 is a versatile, multi-application aesthetic platform developed by Lumenis. The technologies allow for diverse aesthetic treatments, including skin rejuvenation, pigment and vascular lesion removal, scar reduction, hair removal, and tattoo removal.

What are the benefits?

• Skin rejuvenation: The M22 platform offers various options for skin rejuvenation, including Intense Pulsed Light (IPL) treatments that can address skin tone irregularities, sun damage, age spots, and redness associated with rosacea.

• Pigment and vascular lesion removal: The M22 platform's IPL technology can also be used to treat unwanted pigmented lesions, such as freckles, sun spots, and melasma, as well as vascular lesions, such as spider veins, broken capillaries, and angiomas.

• Scar reduction: The ResurFX non-ablative fractional laser technology integrated into the M22 platform can be used to improve the appearance of scars caused by acne, surgery, or injury by stimulating collagen production and promoting skin remodelling.

• Acne treatment: The M22 platform's IPL technology can be used to target the bacteria that cause acne and reduce inflammation, helping to improve the appearance of acne-prone skin.

• Fine lines and wrinkles: The ResurFX fractional laser technology in the M22 platform can stimulate collagen production, which can help to improve the appearance of fine lines and wrinkles, resulting in a smoother and more youthful-looking complexion.

How is the treatment performed?

The treatment procedure may involve the use of a topical anesthetic to numb the treatment area, and protective eyewear may be worn to protect the eyes from the laser light. The treatment duration, number of sessions, and aftercare instructions would depend on the specific condition being treated and the recommendations of the treating healthcare professional.

Is it safe?

Lumenis, the manufacturer of the M22 platform, is a reputable and established company known for its advanced medical and aesthetic laser systems. The M22 platform has been designed and tested to meet safety standards and guidelines set by regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European CE mark for medical devices.

It's important to note that the specific results and benefits of the treatment may vary depending on the individual's skin condition, treatment plan, and other factors. It's essential to consult with our specialists to determine if the treatment is suitable for your specific needs and expectations.

menu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram